Qlaris Bio appointed Fred Guerard, PharmD, as its president and CEO, according to a press release. The company is entering phase 3 development of QLS-111, a novel eye drop for lowering IOP in patients ...

While the Xen 45 gel stent implant showed beneficial long-term outcomes for the treatment of open-angle glaucoma, a substantial proportion of patients needed follow-up operations or bleb needling, ...

Genomics can help to identify people who are more likely to develop glaucoma potentially long before any symptoms of the disease appear. Instead ...

A risk score incorporating genetic variants for open-angle glaucoma is accurate enough to help with diagnosis of the condition, an interim study reveals. Although hundreds of genetic changes are ...

Please provide your email address to receive an email when new articles are posted on . Patients with migraine aged younger than 40 years had higher risk for open-angle glaucoma onset vs. those aged ...

Physiologic AL varies materially with age, sex, height, and ethnicity, undermining fixed AL thresholds as broadly applicable risk stratifiers in typical pediatric myopia. Retinal pathology risk ...

Nucleoside and nucleotide reverse transcriptase inhibitors use remained significantly associated with an increased risk for developing primary open-angle glaucoma after adjustment for family history.

AI could revolutionise glaucoma detection. Here’s 6 things everyone should know - Age and family history are significant risk ...

It is easy to take sight for granted when eyes are working as they should. When vision begins to diminish, people may seek the advice of an eye professional to determine if there is something they can ...